Last --
Change Today 0.00 / 0.00%
Volume 0.0
JNJ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
Sao Paulo
Bogota
All times are local (Market data is delayed by at least 15 minutes).

johnson & johnson (JNJ) Snapshot

Open
--
Previous Close
$171,100
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
2.8B
EX-Date
05/22/14
P/E TM
--
Dividend
$2.87
Dividend Yield
3.05%
Current Stock Chart for JOHNSON & JOHNSON (JNJ)

johnson & johnson (JNJ) Details

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

128,100 Employees
Last Reported Date: 02/21/14
Founded in 1885

johnson & johnson (JNJ) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: $1.5M
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $842.3K
Group Worldwide Chairman and Member of Execut...
Total Annual Compensation: $2.7M
Worldwide Chairman of Pharmaceuticals, Chief ...
Total Annual Compensation: $952.9K
Vice President, General Counsel and Member of...
Total Annual Compensation: $542.3K
Compensation as of Fiscal Year 2013.

johnson & johnson (JNJ) Key Developments

Johnson & Johnson Agrees to Pay $4 Million to Settle Oregon Claims

Johnson & Johnson will pay Oregon $4 million to resolve deceptive marketing claims over recalled metal-on-metal hip implants in its first accord with any governmental unit involving the devices. While the sum is dwarfed by J&J's earlier settlement of patient lawsuits linked to the ASR hip, the agreement may lead the way for additional accords as federal and multistate probes continue into the company's sales of the device. Oregon is at the forefront of the investigations. A group of state attorneys general is investigating how the hips were marketed, while the U.S. Justice Department and the U.S. Attorney's Office in Massachusetts are probing whether the company made false claims or false statements about the devices to federal health care programs.

Johnson & Johnson Appoints D. Scott Davis as Director

Johnson & Johnson announced that its board of directors has appointed D. Scott Davis, Chief Executive Officer and Chairman of United Parcel Service Inc., as a Director of Johnson & Johnson. Mr. Davis will serve on the Audit Committee and the Regulatory, Compliance and Government Affairs Committee of the Board. Mr. Davis has presided over rapid growth in e-commerce delivery, international operations and supply chain and freight at UPS, since being named CEO in 2008. Mr. Davis will be retiring effective September 1, 2014, remaining as non-executive Chairman of the UPS board of directors. In addition to his leadership in public policy, Mr. Davis is on the Board of Honeywell International Inc. He serves as a trustee of the Annie E. Casey Foundation and is a member of The Carter Center Board of Councilors.

Johnson & Johnson Presents at Investment in Innovation (IN3) Medical Device 360 Boston, Jun-18-2014

Johnson & Johnson Presents at Investment in Innovation (IN3) Medical Device 360 Boston, Jun-18-2014 . Venue: Hyatt Regency, Boston, Massachusetts, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:CB $0.00 COP 0.00

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $26.55 USD +0.35
Intel Corp $31.25 USD -0.01
International Business Machines Corp $188.00 USD +0.30
Merck & Co Inc $58.44 USD -0.14
Roche Holding AG SFr.262.70 CHF +0.50
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 20.1x
Price/Sales 4.1x
Price/Book 3.9x
Price/Cash Flow 19.7x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.